Back to search

Article

Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected mice

2022-06-28

Abstract excerpt

<h4>ABSTRACT</h4> As the SARS-CoV-2 pandemic remains uncontrolled owing to the continuous emergence of variants of concern, there is an immediate need to implement the most effective antiviral treatment strategies, especially for risk groups. Here, we evaluated the therapeutic potency of nirmatrelvir, remdesivir, and molnupiravir and their combinations in SARS-CoV-2-infected K18-hACE2 transgenic mice. Systemic tr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
9bec2510-1437-5416-b4f2-6a7b17e11e3f
DOI
10.1101/2022.06.27.497875
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Combination therapy with nirmatrelvir and molnupiravir improves the survival of SARS-CoV-2 infected miceDOI 10.1101/2022.06.27.497875
Select a neighboring publication to make it the new centre.